 | |
| Industry | Pharmaceutical industry |
|---|---|
| Founded | 1970 |
| Defunct | December 23, 2008 |
| Fate | Acquired by Teva Pharmaceutical Industries |
| Headquarters | Montvale, New Jersey |
Key people | Bruce L. Downey, Chairman & CEO William T. McKee, CFO |
| Products | Generic drugs |
| Revenue |  $2.500 billion (2007) |
| $0.128 billion (2007) | |
| Total assets |  $4.761 billion (2007) |
| Total equity | $1.866 billion (2007) |
Number of employees | 8,900 (2007) |
| Footnotes / references [1] | |
Barr Pharmaceuticals was a global specialty and generic drug manufacturer with operations in 30 countries.
Approximately 75% of the company's revenues were from the sale of generic drugs, including 18% of sales which were from the sale of oral contraceptive pills.[1]
It was acquired by Teva Pharmaceutical Industries in 2008 [2] for an estimated $7.46 billion ($10.6 billion in 2023).[3]
- ^ a b "Barr Pharmaceuticals, Inc. 2007 Form 10-K Annual Report". U.S. Securities and Exchange Commission.
- ^ Cite error: The named reference
tevawas invoked but never defined (see the help page). - ^ "Teva buys Barr Pharmaceuticals". The Jerusalem Post | JPost.com. Retrieved 2018-11-18.